DVA Stock Price, Chart, Stats & News

DaVita Inc.
Save
13.67B
Market cap
18.16x
Current P/E
14.53x
Forward P/E
DVA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 30.88% |
Operating margin | 14.91% |
Pretax margin | 9.87% |
Net margin | 5.47% |
Effective tax rate | 21.76% |
ROA | 4.27% |
ROE | -160.63% |
D/E | -23.12x |
Interest coverage ratio | 3.70x |
DVA valuation
P/E | 18.16x |
P/S | 0.76x |
P/B | -20.42x |
P/CF | 7.05x |
P/FCF | 7.88x |
P/OCF | 7.05x |
PEG | -2.64x |
EV multiple | -1.50x |
About
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD).
Similar securities
Based on sector and market capitalization
Report issue











